CAJ | 학술논문

目的：分析缬沙坦联合丹红注射液治疗早期糖尿病肾病患者的临床结果。方法抽选2012年9月-2014年10月，该院接收早期糖尿病肾病患者60例，按编号分成两组(实验组、对照组)，对照组患者借助缬沙坦药物治疗，实验组在缬沙坦基础上添加丹红注射液，比对两组患者临床治疗结果。结果实验组患者临床治疗好转率(93.3%)、不良反应总率和对照组(70.0%)相比，差异性鲜明(P<0.05)。结论借助缬沙坦、丹红注射液药物联合治疗早期糖尿病肾病患者，效果突出，可提高临床治疗好转率，改善临床指标，意义重大，值得使用。
목적：분석힐사탄연합단홍주사액치료조기당뇨병신병환자적림상결과。방법추선2012년9월-2014년10월，해원접수조기당뇨병신병환자60례，안편호분성량조(실험조、대조조)，대조조환자차조힐사탄약물치료，실험조재힐사탄기출상첨가단홍주사액，비대량조환자림상치료결과。결과실험조환자림상치료호전솔(93.3%)、불량반응총솔화대조조(70.0%)상비，차이성선명(P<0.05)。결론차조힐사탄、단홍주사액약물연합치료조기당뇨병신병환자，효과돌출，가제고림상치료호전솔，개선림상지표，의의중대，치득사용。
Objective To analyze the clinical results of valsartan combined with red injection in the treatment of early dia-betic nephropathy. Methods Decimation in September 2012 to October 2014, our hospital received 60 cases of patients with early diabetic nephropathy, according to the number of divided into two groups (experimental group and control group), the control group of patients with valsartan in the treatment of drug, the experimental group in the Valsartan based on added Danhong injection. Patients in both groups than their clinical therapeutic results. Results The clinical treatment of the ex-perimental group (93.3%), the total rate of adverse reactions and the control group(70%), compared with the difference in sharp (P<0.05). Conclusion With valsartan, Danhong injection drug combination therapy in patients with early diabetic nephropathy, outstanding effect, improve the clinical improvement rate and improved clinical indicators, is of great signifi-cance, is worth using.